https://www.selleckchem.com/pr....oducts/ac-fltd-cmk.h
ity and significantly reduced hospitalization. Our findings suggest that this regimen may be considered as an alternative to DA-EPOCH-R in this patient population.Pulmonary hypertension (PH) is a global health issue with a prevalence of 10% in ages 65 years. Right heart failure (RHF) is the main cause of death in PH. We have previously shown that monocrotaline (MCT)-induced PH and RHF are due to an increase in oxidative stress. In this study, probucol (PRO, a strong antioxidant with a lipid-lowering property, versus lovastatin
Like
Comment
Share
